| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 12/10/2009 | WO2009147492A2 Radiologic marker |
| 12/10/2009 | WO2009112488A3 Polyether polyol dendron conjugates with effector molecules for biological targeting |
| 12/10/2009 | WO2009110984A3 Contrast agents for applications including perfusion imaging |
| 12/10/2009 | WO2009110523A3 Dendrimer particle, mri contrast medium, and method of manufacturing a dendrimer particle |
| 12/10/2009 | WO2009106566A3 Therapy selection method |
| 12/10/2009 | WO2009081169A3 Biodegradable contrast agents |
| 12/10/2009 | US20090307785 Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation |
| 12/10/2009 | US20090304719 Activatable binding polypeptides and methods of identification and use thereof |
| 12/10/2009 | US20090304600 Intradialytic administration of sodium thiosulfate |
| 12/10/2009 | US20090304599 Protein Nanoparticles and the Use of the Same |
| 12/10/2009 | US20090304598 Fluorescent membrane intercalating probes and methods for their use |
| 12/10/2009 | US20090304597 Use of an Active Biological Substance in Abnormal Cellular and Viral Membrane Physiologies |
| 12/10/2009 | US20090304596 Methods for Predicting Psychotropic Drugs Which Elicit Weight Gain |
| 12/10/2009 | US20090304595 Animal model and a method for producing an animal model |
| 12/10/2009 | US20090304594 Methods for Predicting Treatment Response Based On the Expression Profiles of Protein and Transcription Biomarkers |
| 12/10/2009 | US20090304593 Detection of the detachment of immobilized contrast agent in medical imaging applications |
| 12/10/2009 | US20090304592 Treatment of metastatic tumors |
| 12/10/2009 | US20090304591 Method and device for optical detection of the eye |
| 12/10/2009 | US20090304590 Therapeutic compositions and methods |
| 12/10/2009 | US20090304589 Radiation sensitive liposomes |
| 12/10/2009 | US20090304588 Biologically excitable cells |
| 12/10/2009 | US20090304583 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 12/10/2009 | US20090304576 Device for delivery of anti-cancer agents to tissue |
| 12/09/2009 | EP2130552A1 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient |
| 12/09/2009 | EP2129664A1 Trisubstituted triazamacrocycli c compounds and their use as contrast agents |
| 12/09/2009 | EP2129407A1 Dehydrated granular composition and biomedical applications thereof |
| 12/09/2009 | EP1119614B1 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 12/09/2009 | CN101600461A Formation and rejuvenation of organs and alcohol damaged organ regeneration through stem cell nutrients |
| 12/09/2009 | CN101600389A Method for influencing and/or detecting magnetic particles in a region of action, magnetic particles and the use of magnetic particles |
| 12/09/2009 | CN101597323A Radioactive isotope labeling polypeptide for tumor imaging |
| 12/09/2009 | CN101596322A Aerial emulsion type ultraphonic contrast agent microballoon and preparation method thereof |
| 12/09/2009 | CN101596321A Novel probe medicament combination and preparation method and application thereof |
| 12/09/2009 | CN101596181A Medicinal composition containing dimeticone/simethicone |
| 12/08/2009 | US7628978 Stabilized preparations for use in metered dose inhalers |
| 12/08/2009 | US7628976 Method of screening for substances which proliferate natural killer cells |
| 12/08/2009 | US7628975 Compositions and methods for detecting and quantifying COX-2 activity and 2-arachidonylgycerol metabolites |
| 12/08/2009 | US7628765 Increasing retrievable cells from a breast duct |
| 12/08/2009 | CA2163012C Anti-egfr single-chain fvs and anti-egfr antibodies |
| 12/03/2009 | WO2009146153A2 Manufacture, transport and delivery of material containing highly polarized nuclei |
| 12/03/2009 | WO2009146099A2 Contrast agents, methods for preparing contrast agents, and methods of imaging |
| 12/03/2009 | WO2009144309A1 Light imaging apparatus, system and method |
| 12/03/2009 | WO2009143720A1 Nanoparticles, methods of making same and cell labelling using same |
| 12/03/2009 | WO2009088876A3 Transgenic non-human animals expressing human blood clotting factors |
| 12/03/2009 | US20090298156 Thymidine Kinase Mutants and Fusion Proteins Having Thymidine Kinase and Guanylate Kinase Activities |
| 12/03/2009 | US20090297567 Method For Ultrasound Triggered Drug Delivery Using Hollow Microbubbles With Controlled Fragility |
| 12/03/2009 | US20090297511 Prevention and treatment of amyloidogenic disease |
| 12/03/2009 | US20090297456 Swallowtail motifs for imparting water solubility to porphyrinic compounds |
| 12/03/2009 | US20090297455 Device for and a method of activating a physiologically effective substance by ultrasonic waves, and a capsule |
| 12/03/2009 | US20090297454 Perfluoroalkyl-Containing Complexes, Process For Their Production As Well As Their Use |
| 12/03/2009 | US20090297453 Diagnostic procedures using direct injection of gaseous hyperpolarized 129xe and associated systems and products |
| 12/03/2009 | US20090297452 Method for quantification of neurotoxin |
| 12/03/2009 | US20090297451 Infection model for developing chemotherapeutic agents |
| 12/03/2009 | US20090297450 Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 12/03/2009 | US20090297449 Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| 12/03/2009 | US20090297448 Quantum Dot Barcode Structures and Uses Thereof |
| 12/03/2009 | US20090297443 Labeled ALPHA4BETA2 Ligands and Methods Therefor |
| 12/03/2009 | US20090297441 Imaging Agents |
| 12/03/2009 | US20090297439 Anti-met monoclonal antibody, fragments and derivatives thereof for use in tumor diagnosis, corresponding compositions and kits |
| 12/03/2009 | US20090297436 Antibodies to il-6 and use thereof |
| 12/03/2009 | DE102008064400A1 Mikrowellenuntersuchung mit einem Kontrastmittel Microwave examination with contrast agents |
| 12/03/2009 | DE10120980B4 Verfahren, Vorrichtung und Computerprogramm zur Bestimmung des Blutflusses in einer Gewebe- oder Organregion Method, apparatus and computer program for determining the blood flow in a tissue or organ region |
| 12/03/2009 | CA2725897A1 Novel substituted pyrazoles, 1,2,4-oxadiazoles, and 1,3,4-oxadiazoles |
| 12/03/2009 | CA2720333A1 Manufacture, transport and delivery of material containing highly polarized nuclei |
| 12/02/2009 | EP2128124A1 Novel hexatriene- -carbonyl compound |
| 12/02/2009 | EP2128095A1 Spherical ferrite nanoparticle and method for production thereof |
| 12/02/2009 | EP2127683A1 Anti-Met monoclonal antibody, fragments and derivatives thereof for use in tumor imaging, corresponding compositions and kits |
| 12/02/2009 | EP2127682A1 X-ray contrast agent based on bismuth oxide-nanoparticles |
| 12/02/2009 | EP2127680A1 Use of carbon nanotube for drug delivery. |
| 12/02/2009 | EP2125857A1 Diagnostic and radiotherapeutic contrast agents and process for their preparation |
| 12/02/2009 | EP2125037A2 Methods and compositions for treating il-4 or il-13 related fibrosis related pathologies |
| 12/02/2009 | EP2125036A1 Formation and rejuvenation of organs and alcohol damaged organ regeneration through stem cell nutrients |
| 12/02/2009 | EP2125035A2 Composition and method for detection of demineralisation |
| 12/02/2009 | EP2125034A2 Methods and materials for identifying the origin of a carcinoma of unknown primary origin |
| 12/02/2009 | EP2125033A2 Compositions and methods relating to organ-, tissue-, and cell-specific antibodies |
| 12/02/2009 | EP2125025A2 Multi-functional drug carriers |
| 12/02/2009 | EP2124986A2 Mycobacterium tuberculosis persistance genes |
| 12/02/2009 | EP2124715A2 Method for influencing and/or detecting magnetic particles in a region of action, magnetic particles and the use of magnetic particles |
| 12/02/2009 | CN101595108A Novel compound having affinity for amyloid |
| 12/02/2009 | CN101594885A Rifaximin anti-rectal dysfunction preparation |
| 12/02/2009 | CN101590245A USPIO-PLA-RGD compound, preparation method and application thereof |
| 12/02/2009 | CN101590244A Application of Pax6 gene mutation mouse produced based on ENU mutation in screening glucagon-like peptide-1 receptor stimulant |
| 12/02/2009 | CN100563719C Ultrasound and MRI combined contrast medium and preparation method thereof |
| 12/02/2009 | CN100563718C Gas-filled microvesicle assembly for contrast imaging |
| 12/01/2009 | US7627363 Polarized light imaging devices and methods |
| 12/01/2009 | US7626074 Method of screening candidate drugs for the treatment of leukemia |
| 12/01/2009 | US7625557 Transimmunization methods incorporating skin immunologic challenges are described for selectively suppressing immune response of recipients of transplanted tissue or cells or monitoring induced anti-cancer immunity |
| 12/01/2009 | US7625550 Observing tumor progression, angiogenesis and/or metastasis in animal models in real time; employs a skin flap over the area to be observed that can be opened and closed reversibly; simultaneous observation of more than one tumor |
| 12/01/2009 | US7625549 Determining the risk of human anti-human antibodies in transgenic mice |
| 12/01/2009 | CA2303229C Pentopyranosylnucleoside, its preparation and use |
| 11/29/2009 | CA2665957A1 Anti-met monoclonal antibody, fragments and derivatives thereof for use in tumor diagnosis, corresponding compositions and kits |
| 11/26/2009 | WO2009143465A1 Method of imaging abnormal deposits or plaques |
| 11/26/2009 | WO2009143388A2 Luminescent multimodal nanoparticle probe system and method of manufacture thereof |
| 11/26/2009 | WO2009142754A1 Dendritic conjugates and methods of use |
| 11/26/2009 | WO2009142189A1 Water-soluble near infrared fluorescent material and multimodal water-soluble near infrared fluorescent material |
| 11/26/2009 | WO2009140763A1 Novel ghrelin analogues |
| 11/26/2009 | WO2009066182A4 Method of treating cancer |
| 11/26/2009 | US20090293138 Animal models carrying tumors expressing human prostate cancer-specific antigen and method for analyzing prevention and treatment efficacy of dendritic cells-derived immunotherapeutics |
| 11/26/2009 | US20090292028 Menthol-containing formulation |
| 11/26/2009 | US20090291460 Assay for transmissible spongiform encephalopathies |
| 11/26/2009 | US20090291048 Leukocyte-binding polypeptides and uses thereof |